Follow The Filings

CON Concentra Group Holdings Par

Health Care, filed as CONCENTRA GROUP HOLDINGS PAR (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 1 Owner
  • Max 0.0%
  • $19M
  • 1 add 1 exit

In 2026 Q2 First Eagle Investment Management added to Concentra Group Holdings Par, while Lee Ainslie sold out.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.03%

Who owns CON

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.03%, was <0.01% Add +62.1% 648,059 $19M History
Lee Ainslie, Maverick Capital exited 2026 Q2 Last 2026 Q1 0.01% Exit −0.01% 27,560 $591K History

1 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CON insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $14.6M sold by 1 insider under 10b5-1 plans
  1. Robert A Ortenzio Director
    Planned sale
    $4.1M 130,000 shares at $31.84 21% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  2. Robert A Ortenzio Director
    Planned sale
    $4M 130,000 shares at $30.50 17% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  3. Robert A Ortenzio Director
    Planned sale
    $3.3M 130,000 shares at $25.00 15% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  4. Robert A Ortenzio Director
    Planned sale
    $3.2M 130,000 shares at $25.00 13% of stake
    Traded May 8 Filed May 11
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 stock grants, 13 share withholdings for taxes, 5 sales back to the company, and 3 gifts.

Congress

1 member of Congress traded CON in the last three years: 1 buy and 1 sale.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Sep 25, 2025 filed Oct 22, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Sep 11, 2025 filed Oct 22, 2025

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,5.02,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 11 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $1.9B $2.16B
Net income $166.54M $166.42M
Net margin * 8.8% 7.7%

Balance sheet

Metric FY2024 FY2025
Total current assets $437.21M $383.1M
Total non-current assets * $2.08B $2.48B
Total assets $2.52B $2.86B
Total current liabilities $307.19M $337.25M
Total non-current liabilities * $1.92B $2.1B
Total equity $275.67M $393.28M

Cash flow

Metric FY2024 FY2025
Cash from operations $274.68M $279.4M
Cash from investing -$71.26M -$414.86M
Cash from financing -$51.53M $32.1M
Net change in cash $151.88M -$103.36M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf